We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

32 hedge funds and large institutions have $4.35M invested in Sophiris Bio, Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

28% more funds holding

Funds holding: 2532 (+7)

21% more capital invested

Capital invested by funds: $3.61M → $4.35M (+$742K)

95% less call options, than puts

Call options by funds: $7K | Put options by funds: $130K

Holders
32
Holders Change
+7
Holders Change %
+28%
% of All Funds
0.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
6
Reduced
4
Closed
3
Calls
$7K
Puts
$130K
Net Calls
-$123K
Net Calls Change
-$119K

SPHS Hedge Fund Activity: Q4 2017 in Review

32 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2017, worth a combined $4.35M — up 21% from $3.61M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SPHS positions and 3 closed out — a net gain of 7 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $435K. The largest seller was Sabby Management, cutting an estimated $605K.

  • 32 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2017, up from 25 in Q3 2017.
  • Funds reported $4.35M of Sophiris Bio, Inc. stock for Q4 2017, up 21% quarter-over-quarter.
  • 10 funds opened new Sophiris Bio, Inc. positions in Q4 2017 and 3 closed out, a net change of +7 holders.
  • The largest Sophiris Bio, Inc. buyer in Q4 2017 was Millennium Management, an estimated $435K added.
  • The largest Sophiris Bio, Inc. seller in Q4 2017 was Sabby Management, an estimated $605K sold.

Based on aggregated 13F filings for Q4 2017.